GlassScriptPhysician profile
David Dai-Quoc Tran
NPI 1902804230
$2,809.90
in general payments reported to CMS, 2019-2025
20 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $589 · 2020: $298 · 2021: $198 · 2022: $141 · 2023: $781 · 2024: $318 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,584.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $628.37 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Smith+Nephew, INC. | $377.95 | 2020-2023 | Renasys Go V2 Home, Pico |
| Bone Support INC. | $349.69 | 2019-2025 | Cerament G, Ceramentbone Void Filler |
| Treace Medical Concepts, INC. | $265.16 | 2022-2023 | |
| Paragon 28, INC. | $218.15 | 2019-2025 | Phantom Fibula Nail |
| Stryker Corporation | $163.74 | 2022-2024 | Prostep Mica |
| Crossroads Extremity Systems, LLC | $151.99 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $111.13 | 2019 | |
| Curonix LLC | $110.70 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Paratek Pharmaceuticals, INC. | $60.53 | 2025 | Nuzyra |
| Corcept Therapeutics | $58.24 | 2020 | |
| Nevro Corp. | $57.24 | 2023 | Senza |
| Wright Medical Technology, INC. | $45.54 | 2019 | |
| Evolution Surgical, INC | $45.07 | 2024 | |
| Urgo Medical North America, LLC | $38.93 | 2025 | Urgok2 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $37.74 | 2024 | Versawrap |
| Amgen INC. | $30.68 | 2020 | |
| Sanofi-Aventis U.S. LLC | $23.26 | 2020 | |
| Companion Medical, INC. | $20.01 | 2019 | |
| Convatec INC. | $15.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.